V. E Salvera Arnoldy, Julianus Yudhistira Tan, H Haris Pastiyanto


Hypoxemia is a condition when there is a lack of oxygen levels in the blood, especially from the arteries. In the early stages of COVID-19, several mechanisms such as intrapulmonary shunting, loss of pulmonary perfusion regulation, intravascular micro thrombus, and impaired diffusion capacity can contribute to the development of arterial hypoxemia, although there is no increase in respiratory work. The prone position is one of the most widely used therapies for patients with hypoxemia because the dorsal area has a large number of alveolar units that are not compressed by the weight of the abdominal cavity and mediastinum, thus creating a more efficient area for gas exchange. This study aimed to determine the effect of the prone position on changes in respiratory parameters of COVID-19 patients. This study used the descriptive correlation method on 27 respondents with purposive sampling. Each respondent was given a prone position for three hours and being observed before, during the three-hour, and after one hour of the prone position administration”. The results of the descriptive analysis of this study showed that the majority of respondents were middle adulthood (63%) with 70% of the respondents being male, 59% having a history of hypertension, and 85% experiencing coagulation disorders. The change in the mean respiratory rate during one hour of supination after three hours of prone position in males was greater than that in females although the mean decrease in oxygen saturation was the same. This shows that the prone position for three hours accompanied by oxygen therapy made an improvement in respiratory status in COVID-19 patients, although it needs further investigation with more respondents and different research methods.


Prone position; respiratory parameters; COVID-19


Full Text:



Albert, R. K., & Hubmayr, R. D. (2000). The prone position eliminates compression of the lungs by the heart. American Journal of Respiratory and Critical Care Medicine, 161(5), 1660–1665.

Ashbaugh, D. G., Boyd Bigelow, D., Petty, T. L., & Levine, B. E. (1967). Acute respiratory distress in adults. The Lancet, 290(7511), 319–323.

Barek, M. A., Aziz, M. A., & Islam, M. S. (2020). Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon, 6(12).

Burhan, E., et al. (2020). Pedoman Tatalaksana. (n.d.).

Bwire, G. M. (2020). Coronavirus: Why men are more vulnerable to Covid-19 than women? SN Comprehensive Clinical Medicine, 2(7), 874–876.

Centers for Disease Control and Prevention. (2020, January 21). Outbreak of 2019 novel coronavirus (2019-ncov) in Wuhan, China. Centers for Disease Control and Prevention.

Centers for Disease Control and Prevention. (n.d.). People with certain medical conditions. Centers for Disease Control and Prevention.

Dhont, S., Derom, E., Van Braeckel, E., Depuydt, P., & Lambrecht, B. N. (2020). The pathophysiology of ‘happy’ hypoxemia in covid-19. Respiratory Research, 21(1).

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: A systematic analysis for the global burden of disease study 2013. (2015). British Dental Journal, 219(7), 329–329.

Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storti, E., … Zoia, E. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-COV-2 admitted to icus of the Lombardy region, Italy. JAMA, 323(16), 1574.

Guan, W.-jie, Ni, Z.-yi, Hu, Y., Liang, W.-hua, Ou, C.-quan, He, J.-xing, Liu, L., Shan, H., Lei, C.-liang, Hui, D. S. C., Du, B., Li, L.-juan, Zeng, G., Yuen, K.-Y., Chen, R.-chong, Tang, C.-li, Wang, T., Chen, P.-yan, Xiang, J., … Zhong, N.-shan. (2020). Clinical characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720.

Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (covid-19) outbreak – an update on the status. Military Medical Research, 7(1).

Lieberman, N. A., Peddu, V., Xie, H., Shrestha, L., Huang, M.-L., Mears, M. C., Cajimat, M. N., Bente, D. A., Shi, P.-Y., Bovier, F., Roychoudhury, P., Jerome, K. R., Moscona, A., Porotto, M., & Greninger, A. L. (2020). In vivo antiviral host transcriptional response to SARS-COV-2 by viral load, sex, and age. PLOS Biology, 18(9).

Lippi, G., Wong, J., & Henry, B. M. (2020). Hypertension and its severity or mortality in coronavirus disease 2019 (Covid-19): A pooled analysis. Polish Archives of Internal Medicine.

Liu, Y., Mao, B., Liang, S., Yang, J.-W., Lu, H.-W., Chai, Y.-H., Wang, L., Zhang, L., Li, Q.-H., Zhao, L., He, Y., Gu, X.-L., Ji, X.-B., Li, L., Jie, Z.-J., Li, Q., Li, X.-Y., Lu, H.-Z., Zhang, W.-H., … Xu, J.-F. (2020). Association between age and clinical characteristics and outcomes of COVID-19. European Respiratory Journal, 55(5), 2001112.

LoMauro, A., & Aliverti, A. (2018). Sex differences in respiratory function. Breathe, 14(2), 131–140.

Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016). Global disparities of hypertension prevalence and control. Circulation, 134(6), 441–450.


  • There are currently no refbacks.

Copyright (c) 2021 V. E Salvera Arnoldy, Julianus Yudhistira Tan, H Haris Pastiyanto

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

favicon Faculty of Nursing | Universitas Pelita Harapan | Lippo Karawaci, Tangerang, Indonesia, 15811 |